NRP2 and cervical carcinoma: Our future studies will examine whether miR-331-3p and its target, NRP2, are useful clinical diagnostic and/or prognostic markers for histological and cytological examination using tissue specimens and liquid-based cytology in the screening and diagnosis of cervical cancer.